DentalReach Academic Editor:
A study from the University of São Paulo in Brazil suggests that children who regularly take anti-inflammatory medications may be at risk for dental. The practical reading is to separate established principles from emerging claims, then match the recommendation to diagnosis, risk, patient preference and operator competence.
DentalReach Critical Appraisal:
For children, age alone is insufficient. Cooperation, caries activity, pulpal diagnosis, restorability, eruption stage and the family’s ability to maintain care all influence treatment. Consent and communication should remain developmentally appropriate.
DentalReach Practice Perspective:
The prescribing question is narrower than “does it work?” Indication, source control, allergy, interactions, resistance, adverse effects and the shortest effective regimen all belong in the decision.
DentalReach Evidence Review:
The key unresolved issue is generalisability: which patient, lesion or procedural feature would make you choose another approach? Defining that boundary is often more educational than simply agreeing with the conclusion.
DentalReach Clinical Contributor:
For a connected reading pathway, review Safer Pediatric Dental Pain Relief: New Guidelines Promote Nonopioid Solutions — dentalreach.today/safer-pediatric-dental-pain-relief-new-guidelines-promote-nonopioid-solutions. Together, the resources broaden the discussion from core principles to case selection and follow-up.
Sign in to join this discussion.